Kaynakça
Kelaidi C, Chevret S, De Botton S, Raffoux E, Guerci A, Thomas X, et al. Improved outcome of acute promyelocytic leukemia with high WBC counts over the last 15 years: the European APL Group experience. J Clin Oncol 2009; 27: 2668-76.
Gunning K, Pippitt K, Kiraly B, Sayler M. Pediculosis and scabies: treatment update. Am Fam Physician 2012; 86: 535-41.
Astudillo L, Loche F, Reynish W, Rigal-Huguet F, Lamant L, Pris J. Sweet's syndrome associated with retinoic acid syndrome in a patient with promyelocytic leukemia. Ann Hematol 2002; 81: 111-4.
Morio K, Mizuki M, Sozu T, Uejima E. Risk factors for cytarabine-induced cutaneous toxicity in patients with haematological malignancies. Chemotherapy 2014; 60: 168-73.
Haidari W, Strowd LC. Clinical characterization of leukemia cutis presentation. Cutis 2019; 104: 326-30.
Trendelenburg M, Büchner S, Passweg J, Rätz Bravo AR, Gratwohl A. Disseminated scabies evolving in a patient undergoing induction chemotherapy for acute myeloblastic leukaemia. Ann Hematol 2001; 80: 116-8.
